Skip to main content

Table 3 Pooled estimates of odds ratio and corresponding 95% confidence intervals of patient demographic characteristics and severe dengue

From: Clinical predictors of severe dengue: a systematic review and meta-analysis

Predictors

Number of studies

Pooled

Heterogeneity test

OR (95% CI)

I2 (%)

P-value

Demography

 Children

22

1.96 (1.22–3.13)

90.00

< 0.001

 Female

114

1.20 (0.79–1.82)

80.3

< 0.001

 Secondary infection

29

3.23 (2.28–4.57)

33.20

0.044

Co-morbidities

 Diabetes

10

2.88 (1.72–4.81)

40.9

0.085

 Cardiovascular disease

4

2.27 (0.38–13.71)

70.8

0.016

 Obesity

5

0.76 (0.41–1.40)

32.9

0.202

 Renal disease

4

4.54 (1.55–13.31)

45.1

0.162

 Hypertension

9

1.82 (0.98–3.37)

63.1

0.006

Warning signs

 ↑Hct & ↓Plt*

7

5.13 (1.61–16.34)

88.1

< 0.001

 Abdominal pain

55

2.00 (1.49–2.68)

70.9

< 0.001

 Vomiting

53

1.80 (1.43–2.26)

62.8

< 0.001

 Lethargy

10

2.73 (1.05–7.10)

85.1

< 0.001

 Hepatomegaly

47

5.92 (3.29–10.65)

89.3

< 0.001

 Ascitis

22

6.30 (3.75–10.60)

67.7

< 0.001

 Pleural effusion

25

5.72 (3.24–10.10)

76.3

< 0.001

 Gum bleeding

12

2.00 (0.86–4.66)

56.4

0.008

 Epistaxis

11

1.85 (0.72–4.70)

64.4

0.002

 Hemetemesis

5

12.35 (4.97–30.72)

52

0.080

 Melena

9

4.05 (1.64–10.00)

78.1

< 0.001

 Skin bleeding

4

1.38 (0.47–4.06)

73.5

0.010

 GI bleeding

5

9.49 (2.75–32.70)

78.4

0.001

  1. *Increase in haematocrit values with concurrent decrease in platelet count
  2. OR odd ratio, CI confidential interval